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Abstract Id-like helix-loop-helix (HLH) transcription factors 
are involved in the regulation of proliferation and differentiation 
of several cell types. We isolated 5' regulatory region of mouse 
Id2 gene and demonstrated that it contains several E-box clusters. 
These E-boxes mediate stimulatory effects of basic-HLH 
(bHLH) transcription factors ME1, ME2, and NSCL1 on Id2 
promoter activity. Co-expression of Id2 blocks the stimulatory 
effect of bHLH transcription factors which suggests the presence 
of feedback loops in Id2 transcriptional regulation. Overexpres- 
sion of NSCL1 in F9 cells blocks the downregulation of Id2 gene 
expression during retinoic acid induced differentiation. Our data 
demonstrate that bHLH transcription factors regulate Id2 gene 
expression. 
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1. Introduction 
Helix-loop-helix (HLH) transcription factors regulate several 
developmental processes in different organisms. These factors 
form an interacting network of transcription factors that regu- 
late many genes including HLH transcription factor genes 
themselves [1,2]. Different HLH transcription factors poten- 
tially interact with each other by forming heterodimers [3]. The 
HLH transcription factors which form heterodimers are 
grouped into four classes: class A includes MEI (HEB, REB, 
HTF4), ME2 (ITF2), and E2A which are expressed ubiqui- 
tously [3 10]; class B includes cell type and tissue specific pro- 
teins such as NSCL, NEX, MASH- l ,  MASH-2, MyoD and 
others [11,14]; HES-family includes negatively acting transcrip- 
tional regulators HES-1, HES-2, HES-3, HES-5 [15 18]; and 
Id-like family includes transcriptional regulators lacking the 
basic, DNA binding domain such as Idl,  Id2, Id3, and Id4 
[19-22]. The activity of each individual HLH transcription fac- 
tor depends on the complexes formed, and how these com- 
plexes bind to DNA and interact with the basic transcriptional 
complex. For example, class A or class B bHLH transcription 
factors form non-DNA-binding transcriptionally inactive 
heterodimers with Id-like molecules [21]. This is the manner in 
which Id-like proteins regulate onset of myogenesis. Idl forms 
inactive complexes with myogenic HLH transcription factors, 
and, only after the expression of Idl decreases, the myogenic 
HLH transcription factors become active [23]. 
During the nervous ystem development, the Id2 gene has a 
changing expression pattern [24]. At early stages of neurogene- 
sis, Id2 is active in proliferating neuroblasts. After the first 
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neuronal populations are born, the expression of Id2 is down 
regulated in neuroepithelial cells and continues to be high in 
early borned neurons. Class A bHLH transcription factors 
MEI [9] and El2 [25] are expressed in proliferating neuroblasts 
and their expression is downregulated after cells migrate out 
from the ventricular zone and initiate differentiation. ME2 
(ITF2), a member of class A bHLH family, is expressed in both 
proliferating neuroblasts and differentiating neurons in several 
regions of the developing nervous system [10]. Neuronal class 
B bHLH transcription factor NSCL1 is expressed transiently 
during the period when the first born neurons tart differentia- 
tion, and the expression is limited to the subependymal layer 
of the neuroepithelium [13]. Based on the expression pattern of 
HLH genes during neurogenesis and on the presence of several 
E-boxes in the Id2 gene regulatory region, we hypothesize that 
the expression of Id2 gene is regulated by the HLH transcrip- 
tion factors. In this paper we demonstrate that Id2 gene pro- 
moter has two clusters of E-box sequences and that its activity 
is stimulated by the bHLH transcription factors and suppressed 
by the Id2. 
2. Materials and methods 
2.1. Plasmid construction 
Mouse Id2 promoter CAT constructs, -2182 CAT, -1283 CAT, -508 
CAT and -114 CAT were generated as described [24] using BamHI, 
PstI, HindIII, and EcoRI restriction enzymes. Promoter fragments 
were cloned into the BglII site of the pBLCAT3 vector [26] using BglII 
linkers. All the CAT constructs were sequenced using primer in the 
CAT gene. Full length cDNAs for bHLH transcription factors MEla, 
ME2, Id2 [9,10,24], and NSCL1 [13] were cloned into eukaryotic 
expression vector pRcCMV (Invitrogen). Double stranded mutated 
E-box cluster A and B oligonucleotides were cloned into the blunted 
XbaI site of the pBLCAT2 [26] reporter plasmid in the front of herpes 
simplex virus thymidine kinase promoter. 
2.2. Cell culture 
Neuroblastoma/glioma hybrid NGI08 115 cells (gift from Dr. M. 
Fishman) and teratocarcinoma F9 cells (ATCC) were grown in Dul- 
becco's modified Eagle's medium (DMEM) containing 10% fetal bo- 
vine serum (Gibco). F9 cells were differentiated with all-trans retinoic 
acid (5 x 10 -7 M) and dibutyryl cyclic AMP (1 mM) treatment. To 
establish cell lines overexpressing ME2 and NSCL1 bHLH transcrip- 
tion factors, ME2 and NSCL1 expression plasmids (pRcCMV-ME2 
and pRcCMV-NSCL1, respectively) were transfected into F9 cells fol- 
lowed by selection with G418 (400/lg/ml) for 21 30 days. Expression 
of ME2 and NSCL1 was analyzed by the Northern blot and cell lines 
with high expression of transgene were used for further analyses. 
2.3. DNA transfection and CAT assays 
Cells were transfected with 15/lg of total plasmid DNA using calcium 
phosphate precipitation method in 60 mm dishes (1-3 x 105 cells/dish). 
Five ¢tg of reporter DNA construct and 10/,tg of eukaryotic expression 
construct were used for each transfeetion. The medium was changed to 
normal growth media 12 to 18 h after transfection. Cells were harvested 
48 h later and CAT assays were performed as described [9,24]. Quanti- 
ration of acetylation ratios was obtained by PhosphorImager analysis 
(Molecular Dynamics). To normalize transfection efficiencies, cells 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(95)01128-5 
280 K. Neuman et al./FEBS Letters 374 (1995) 279-283 
were cotransfected with l ~g of the pRcRSVlacZ plasmid. All the CAT 
activities are normalized to total protein and lacZ activity. The CAT 
assay values represent the mean of at least hree independent transfec- 
tions. 
2.4. Northern blot analysis' 
Total RNA from untreated and retinoic acid and dBcAMP treated 
control and ME2 or NSCL1 overexpressing F9 cells was isolated using 
acid guanidinium/phenol/chloroform extraction procedure [28]. 
Twenty five micrograms of total RNA were run in each lane and 
fractionated on 1.2% agarose-formaldehyde gel before transfer onto a 
nylon membrane (Hybond N, Amersham). The amount and quality of 
transferred RNA were monitored by methylene blue staining of the 
filters before hybridization. The full length Id2 cDNA was radiolabeled 
with [~-32p]dCTP using the Multiprime DNA labeling system (Amer- 
sham) and used as a probe. The blots were washed at high stringency 
(0.2x SSC, 65°C) and exposed to X-ray film for 2 days. 
3. Results 
3.1. Analysis of the 5' end of the Id2 gene 
A phage clone containing the 5' end of the Id2 gene that 
extended for 2,661 nucleotides upstream of the translation ini- 
tiation codon has been isolated and sequenced (GeneBank ac- 
cession umber U 10994). The transcription i itiation sites were 
mapped by primer extension and RNase protection analyses 
[24,27]. 
The sequence of Id2 gene proximal promoter contains a 
consensus TATA box (31 nucleotides from the tanscriptional 
start site), Spl binding site, and two CAAT boxes close to the 
TATA box. Two E-box clusters and several single E-boxes are 
localized in the sequenced region of the Id2 gene 5' end (Fig. 
1A). The presence of E-boxes in the 5' regulatory region raises 
the possibility that Id2 gene is regulated by the HLH transcrip- 
tion factors and is a subject to negative feedback regulatory 
loops. 
3.2. Effect of basic helix-loop-helix transcription Jitctors on the 
activity of ld2 promoter 
To determine sequences responsible for the effects of bHLH 
transcription factors on mouse Id2 gene, various portions of the 
5'-flanking region were fused to the bacterial chloramphenicol 
acetyl transferase (CAT) gene as a heterologous reporter gene 
[24]. The constructs carrying different fragments o f the Id2 gene 
5' sequence (Fig. 1A) were transfected into neuroblastoma/ 
glioma NG108-115 hybrid cell line together with NSCLI, 
ME1, ME2, and Id2 cDNAs cloned into an expression vector 
under control of CMV promoter. Our previous work demon- 
strated that the activity of longest Id2 promoter-reporter con- 
struct (-2182 CAT) in NG108-115 cells is two times higher 
compared to the shortest reporter construct (-114 CAT) [24]. 
Cotransfection ofthe bHLH transcription factors NSCL, ME 1, 
ME2 with the -2182 CAT construct stimulate the promoter 
activity around six fold (Fig. 1B). Deletion of the E-box cluster 
A (construct -1283 CAT, Fig. 2B) reduces the effect of bHLH 
transcription factors on Id2 promoter about two times (Fig. 
1B). Deletion of both E-box clusters, A and B, (construct -508 
CAT) further educes the bHLH transcription factor mediated 
stimulation of promoter activity (Fig. 1B). Deletion of all E- 
boxes (construct -114 CAT) eliminates the effect of NSCL and 
MEI, but ME2 still stimulates 114 bp promoter fragment activ- 
ity. Co-expression of Id2 suppresses the stimulatory effect of 
bHLH transcription factors as well as basal CAT activity for 
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Fig. 1. Effect of different HLH transcription factors on the activity of 
Id2 promoter in transient assays. (A) Schematic representation f Id2 
gene promoter egion and CAT constructs. Restriction sites used in 
generation of CAT constructs and E-box clusters A, B, and C are 
indicated. (B) Various combinations of NSCL1, ME1, ME2, and Id2 
expression constructs (5/~g) were transfected into NGI08-15 cells, as 
indicated below the panel, together with -2182 CAT, -1283 CAT, -508 
CAT, and -114 CAT reporter constructs (2/lg). The CAT activities, 
normalized to the expression of RSVIacZ construct cotransfected as an 
internal standard, represent the average of three experiments and are 
expressed relative to the value obtained by transfection of reporter 
construct and pRcCMV expression plasmid without insert (line 1). 
Standard eviations were less than 25% from the average values in all 
experiments. 
all the reporter constructs containing E-box sequences. Inter- 
estingly, Id2 almost completely blocks the stimulatory effect of 
ME1 and ME2 but reduces the effect of NSCL by only about 
50% (Fig. 1B). 
Mutations were introduced into individual E-boxes in clus- 
ters A and B to analyze the role of individual E-boxes on the 
stimulation of Id2 gene promoter by NSCL, ME1, and ME2 
bHLH transcription factors. Mutated oligonucleotides con- 
taining clusters A and B were cloned in the front of Herpes 
simplex virus thymidine kinase (HSV TK) gene promoter. Clus- 
ter A contains three E-box sequences (Fig. 2A), and we mutated 
these E-boxes individually (Fig. 2A, oligonucleotides A1, A2, 
and A3) and all three together (Fig. 2A, oligonucleotide A4). 
Transient CAT assays using mutated oligonucleotides in front 
of TK CAT reporter gene demonstrated that mutation in the 
first E-box (A1) resulted in about a 60% reduction of NSCL, 
ME1, and ME2 stimulated CAT activity (Fig. 2B). Mutation 
in the second E-box reduced NSCL1 and ME1 mediated stim- 
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Fig. 2. Effect of mutations in E-box cluster A on heterologous promoter 
activity. (A) Nucleotide sequences of wild type (Wild type A) and 
mutant (A1, A2, A3, and A4) E-box cluster A. E-box sequences are 
underlined and mutations are indicated by asterisk (*). (B) Wild type 
and mutated E-box cluster A containing oligonucleotides were cloned 
in the front of TK promoter in pBLCAT2 reporter plasmid. Reporter 
plasmid containing wild type (Wild type A) and mutated oligonucleo- 
tides (A1, A2, A3, and A4) were cotransfected with NSCL1, ME1, 
ME2, and Id2 expression plasmids into NG108-115 cells. The CAT 
activities, normalized to the expression of RSVIacZ construct cotrans- 
fected as an internal standard, represent the average of three experi- 
ments and are expressed relative to the value obtained by transfection 
of reporter construct and pRcCMV expression plasmid without insert 
(line 1). Standard deviations were less than 25 % from the average values 
in all experiments. 
ulation of CAT activity about 30% and did not affect ME2 
mediated induction. Mutation in the third E-box did not affect 
stimulatory effect of  any of  the bHLH transcription factors. By 
contrast, mutations in all three E-boxes (A4) eliminated the 
stimulatory effect of  all bHLH transcription factors. We also 
introduced mutations into cluster B E-boxes. Mutations in the 
first or second E-box (Fig. 3A, oligonucleotides B1 and B2) 
resulted in about a 50% reduction of  CAT activity stimulated 
by the different bHLH transcription factors (Fig. 3B). Double 
mutation (oligonucleotide B3) completely blocked the effect of 
bHLH transcription factors. These data demonstrate that Id2 
promoter E-boxes function as enhancers in the front of  a 
heterologous promoter, and that bHLH transcription factors 
NSCL,  ME1, and ME2 have different effects on individual 
E-boxes. 
3.3. NSCL  blocks downregulation of  ld2 in differentiating F9 
cells 
We generated teratocarcinoma F9 cell lines which overex- 
pressed ME2 and NSCL1 cDNAs  under the control of  CMV 
promoter (data not shown) to test the hypothesis that these 
bHLH transcription factors regulate expression of  the Id2 gene. 
Expression of the Id2 gene is suppressed in normal F9 cells after 
induction of differentiation with all-trans retinoic acid and di- 
butyryl cAMP (Fig. 4). Downregulation of  Id2 gene is less 
extensive in ME2 overexpressing cells and does not occur in 
NSCL 1 overexpressing cells (Fig. 4). Although Fig. 4 represents 
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Fig. 3. Effect of mutations in E-box cluster B on heterologous promoter 
activity. (A) Nucleotide sequences of wild type (Wild type B) and 
mutant (BI, B2, and B3) E-box cluster B. E-box sequences are under- 
lined and mutations are indicated by asterisk (*). (B) Wild type and 
mutated E-box cluster B containing oligonucleotides were cloned in the 
front of TK promoter in pBLCAT2 reporter plasmid. Reporter plasmid 
containing wild type (Wild type B) and mutated oligonucleotides (B1, 
B2, and B3) were cotransfected with NSCL1, ME1, ME2, and ld2 
expression plasmids into NG 108 115 cells. The CAT activities, normal- 
ized to the expression of RSVlacZ construct cotransfected as an internal 
standard, represent the average of three experiments and are expressed 
relative to the value obtained by transfection of reporter construct and 
pRcCMV expression plasmid without insert (line l). Standard devia- 
tions were less than 25% from the average values in all experiments. 
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Fig. 4. Northern blot analyses of retinoic acid and dibutyryl cAMP 
induced ownregulation f Id2 expression i  ME2 and NSCLI overex- 
pressing F9 teratocarcinoma cells. Total RNA was isolated from con- 
trol (0), treated 2and 5 days (2d and 5d respectively) with retinoic acid 
and dibutyryl cAMP normal F9 (F9), and ME2 and NSCL1 overex- 
pressing F9 cells (F9 + ME2 and F9 + NSCL, respectively). Overcx- 
pression of NSCL1 in F9 cells blocks retinoic acid and dibutyryl cAMP 
induced ownregulation f ld2 gene. 
the data obtained from one ME2 and NSCLI overexpressing 
clone, identical results were obtained with four additional 
clones as well as a pool populations of ME2 and NSCL1 over- 
expressing clones. Additionally, analyses of cell clones and pool 
populations of cells overexpressing ME2 and NSCLI cDNAs 
with mutations that disrupt open reading frame did not result 
in stimulation of Id2 expression in differentiating F9 cells. 
These data suggest that NSCL1 is an essential regulator of ld2 
expression i  differentiating cells. 
4. Discussion 
In this paper, we explore the possibility that HLH transcrip- 
tion factors are at least partially responsible for the expression 
of Id2 gene. Recently, it has been demonstrated that human 
Id2A gene promoter equires presence of Sp-1 and ATF-like 
sites in the proximal promoter to be expressed in C2 cells, 
whereas these sites are not essential for the expression i  non- 
muscle cells, including HeLa and 10TI/2 cells [29]. Whether the 
proximal promoter Sp-1 and ATF-like sites are important for 
the Id2 expression in other tissues and cell types is unknown. 
The presence of E-box sequences in the 2182 bp 5' regulatory 
region suggests that HLH transcription factors may regulate 
expression of Id2 gene. We demonstrated that bHLH transcrip- 
tion factors MEI, ME2, and NSCLI stimulate the Id2 pro- 
motet activity, and that Id2 itself suppresses basal as well as 
stimulated promoter activity. Suppression of basal promoter 
activity by Id2 argues that HLH transcription factors present 
in NG108 115 cells and interacting with Id2 protein, stimulate 
Id2 gene expression. Previously, we have shown [24] that 508 
bp promoter fragment (-508 CAT) which contains E box cluster 
C is essential for down-regulation f Id2 promoter activity 
during differentiation of NG108-115 cells. The role of E box 
cluster C and HLH transcription factors in this down-regula- 
tion is unknown. 
Expression of several class A bHLH transcription factors 
and Id-like transcriptional regulators i downregulated during 
differentiation [9,24,25,30,31] and stimulated when cells are 
induced to proliferate [32,33]. Also, overexpression f Id2 po- 
tentiates proliferation which is likely related to its ability to 
bind Rb protein [34]. It has been suggested that Id-like tran- 
scriptional regulators function as general inhibitors of differen- 
tiation and activators of proliferation [23,35]. How these two 
different functions are coordinated in different cell types re- 
mains to be characterized. However, it is clear that the expres- 
sion level of ld-like proteins is a critical parameter in the regu- 
lation of proliferation and differentiation. 
In this paper, we demonstrate hat bHLH transcription fac- 
tors regulate Id2 gene promoter activity. In developing nervous 
system, class A bHLH transcription factors [9,25] and Id2 [24] 
are expressed in the ventricular zone where proliferating cells 
are localized. Expression of El2 and MEI become downregu- 
lated in developing neurons when they migrate from the ven- 
tricular zone. Also, Id2 expression is reduced in differentiating 
neurons with the except of first born neurons which continue 
to express Id2 during their lifetime [24]. This similarity in ex- 
pression patterns is additional evidence that class A bHLH 
transcription factors may be necessary for the expression of Id2 
in neuroblasts. At the time when first born neurons migrate 
from the ventricular zone, class b bHLH gene NSCLI becomes 
active in these neurons [13]. The presence of NSCL1 transcrip- 
tion factors in differentiating first born neurons may be neces- 
sary for the continuous expression of Id2 gene. This hypothesis 
is supported by our experimental data obtained using NSCL1 
overexpressing F9 teratocarcinoma cells. Expression of Id2 
gene is downregulated in RA and dBcAMP treated F9 cells but 
overexpression f NSCLI blocks the RA and dBcAMP in- 
duced suppression of Id2 gene in F9 cells. 
At this point, we do not know whether the E-boxes identified 
in this study are essential for properly directing Id2 gene expres- 
sion during development or in adult organism. Thus, the phys- 
iological role of the E-boxes will require further investigations 
using mutational nalyses of Id2 promoter on transgenic mice. 
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